Should physicians initiate β-blocker therapy in patients undergoing non-cardiac surgery? Insights from the POISE trial

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 11, 2008, Pages 616-618

  Alonso Coello, Pablo ^a,b   Paniagua, Pilar ^c   Mizera, Ryszard ^d   Devereaux, Philip J ^d  

^a HOSPITAL SANT PAU   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; FATTY ACID; METOPROLOL SUCCINATE; PLACEBO;

BRADYCARDIA; DRUG WITHDRAWAL; EDITORIAL; FATTY ACID BLOOD LEVEL; GENERAL SURGERY; HEART ARREST; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; HYPOTENSION; NONCARDIAC SURGERY; PERIOPERATIVE COMPLICATION; PHYSIOLOGICAL STRESS; PREOPERATIVE TREATMENT; STROKE; SURGICAL MORTALITY; SURGICAL RISK; TACHYCARDIA;

EID: 57149113757     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.502     Document Type: Editorial

References (20)

1. Weiser TG, Regenbogen SE, Thompson KO, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008; 372: 139-144.
2. Devereaux PJ, Goldman L, Cook DJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005; 173: 627-634.
3. Sametz W, Metzler H, Gries M, et al. Perioperative catecholamine changes in cardiac risk patients. Eur J Clin Invest. 1999; 29: 582-587.
4. Parker SD, Breslow MJ, Frank SM, et al. Catecholamine and cortisol responses to lower extremity revascularization: correlation with outcome variables. Crit Care Med. 1995; 23: 1954-1961.
5. Mangano DT, Wong MG, London MJ, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery - II: incidence and severity during the 1st week after surgery. J Am Coll Cardiol. 1991; 17: 851-857.
6. Stone JG, Foex R Sear JW, et al. Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth. 1988; 61: 675-679.
7. Stone JG, Foex P, Sear JW, et al. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology. 1988; 68: 495-500.
8. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrythmias. Lancet. 1994; 343: 155-158.
9. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces post-operative myocardial ischemia. Anesthesiology. 1998; 88: 7-17.
10. Viljoen JF, Estafanous FG, Kellner GA. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg. 1972; 64: 826-830.
11. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996; 335: 1713-1720.
12. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999; 341: 1789-1794.
13. Devereaux PJ, Yusuf S, Yang H, et al. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ. 2004; 171: 245-247.
14. Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006; 152: 983-990.
15. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded murticentre trial. BMJ. 2006; 332: 1482.
16. Palda VA, Detsky AS. Clinical guideline, part II. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med. 1997; 127: 313-328.
17. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery J Am Coll Cardiol 2007; 50: 1707-1732
18. Devereaux PJ, Yang H, Guyatt GH, et al: POISE Trial Investigators. Rationale, design, and organization of the PeriOperative ISchemic Evalualion (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J. 2006; 152: 223-230.
19. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371: 1839-1847
20. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005; 331: 313-321.